Cargando…
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
BRCA1 and BRCA2 mutations are not uncommon in breast cancer patients. Western studies show that such mutations are more prevalent among younger patients. This study evaluates the prevalence of germline mutations in BRCA1 and BRCA2 among breast cancer patients diagnosed at age 40 or younger in Jordan...
Autores principales: | Abdel-Razeq, Hikmat, Abujamous, Lama, Abunasser, Mahmoud, Edaily, Sara, Bater, Rayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295261/ https://www.ncbi.nlm.nih.gov/pubmed/34290354 http://dx.doi.org/10.1038/s41598-021-94403-1 |
Ejemplares similares
-
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020) -
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022) -
Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022) -
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018)